samedan logo
 
 
 
spacer
home > pmps > spring 2019 > pharmaceutical fraud
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pharmaceutical Fraud

In 2011, a man was jailed for eight years for conducting counterfeit medicine fraud that amounted to a retail value of £4.7 million. As a result of him being able to infiltrate the pharmaceutical supply chain, 25,000 packets of counterfeit medication reached pharmacies and patients all over the UK. These knock-off tablets were used to treat heart disease, pancreatic cancer, and mental illnesses and had none, or only part, of the active ingredient they were supposed to contain. Sadly, this meant that those people’s illnesses were left to take their course.

Unfortunately, while tremendous effort goes into ensuring the effective operation of every pharma supply chain, the losses are staggering. With the global counterfeit drug market worth £154 billion and one million people dying due to fake medicine around the world each year, a reliable supply chain is paramount. Enter: blockchain. While blockchain harnesses a plethora of benefits, addressing its shortcomings is necessary to ensure that implementation of the technology can be utilised to its full effect.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Karim Jawhary is the Senior Industry Director of Life Sciences and Healthcare at Unisys. He brings over 15 years’ experience to the technology industry, with deep expertise in cloud computing, Software-as-a- Service, Big Data, and security solutions. Prior to joining Unisys, Karim served at TIBCO Software as a Senior Account Executive, leveraging the TIBCO connected intelligence cloud to augment business intelligence and agility through analytical insights. He also worked at Akamai Technologies as an Enterprise Account Executive where he built a strong life sciences and healthcare practice. Karim holds a bachelor’s degree in business management from East Stroudsburg University of Pennsylvania, US, and has pursued continuing education in force management, Miller Heiman strategic selling, and Sales Performance International solution selling.
spacer
Karim Jawhary
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Clinical trials in the post Brexit Europe

While negotiations are still ongoing, the structure of the post-Brexit medicine testing and approval process is still unclear, and the UK government has so far ruled out an extension to the transition period which is due to come to an end at the end of this year.
More info >>

White Papers
 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement